ATP1A3 and early-infantile DEE: There is growing evidence that ATP1a3 mutations are involved in many pediatric neurological diseases such as alternating hemiplegia, sensorineural hearing loss syndrome or again rapid-onset dystonia-Parkinson and early infantile epileptic encephalopathy [49–52].